Naseem Shah who has tested positive for COVID-19 home for isolation will join the team for tri-nation series.
With the tri-nation series and T20 World Cup a few weeks away, fans were worried regarding his health and inclusion in the squad. Naseem Shah is among the main pace attack on Pakistan. PCB has ensured that Shah will join the squad for the tri-nation series on Sunday. He will self-isolate at home for two days. He, however, will not play the next two matches against England. According to the PCB spokesperson, a medical panel of PCB will continue to monitor his health.
Pacer Naseem Shah was confirmed to have contracted COVID-19 on Thursday. Reports emerge hours after PCB confirmed that the pacer has been diagnosed with pneumonia.
Alhamdulillah, I am feeling better and recovering well. Thank you for keeping me in your prayers!
May Allah protect us all. Duaon main yaad rakhaye ga!
See you all very soon!
— Naseem Shah (@iNaseemShah) September 29, 2022
Owing to his health, Shah has been ruled out of the T20I series against England after testing positive for the virus. He was diagnosed with pneumonia on Wednesday after he was shifted to the hospital.
Pakistani pacer Naseem Shah was admitted to hospital ahead of the fifth T20I between Pakistan and England scheduled on Wednesday at Gaddafi Stadium Lahore.
Read more: Naseem Shah test positive for COVID-19: media reports
In his tweet on Thursday, the pacer said he is recovering well but asked the fans to keep him in their prayers.
“Alhamdulillah, I am feeling better and recovering well. Thank you for keeping me in your prayers! May Allah protect us all. Duaon main yaad rakhaye ga! See you all very soon!,” said Naseem Shah in a tweet.
Fans expressed relief after hearing from the pacer regarding his health.
Another pacer Shaheen Shah Afridi is already out of the squad due to his knee injury. Afridi missed Asia Cup 2022 and a seven T20I match series against England.
Shaheen Shah is expected to join the Pakistan squad for the tri-nation series ahead of the T20 World Cup 2022.